β-adrenergic Receptor Stimulation Revealed a Novel Regulatory Pathway via Suppressing Histone Deacetylase 3 to Induce Uncoupling Protein 1 Expression in Mice Beige Adipocyte
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
β-adrenergic Receptor Stimulation Revealed a Novel Regulatory Pathway via Suppressing Histone Deacetylase 3 to Induce Uncoupling Protein 1 Expression in Mice Beige Adipocyte
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 8, Pages 2436
Publisher
MDPI AG
Online
2018-08-17
DOI
10.3390/ijms19082436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Butyrate stimulates adipose lipolysis and mitochondrial oxidative phosphorylation through histone hyperacetylation-associated β3 -adrenergic receptor activation in high-fat diet-induced obese mice
- (2017) Yimin Jia et al. EXPERIMENTAL PHYSIOLOGY
- The histone deacetylase inhibitor sodium butyrate improves insulin signalling in palmitate-induced insulin resistance in L6 rat muscle cells through epigenetically-mediated up-regulation of Irs1
- (2017) Sabrina Chriett et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Synthesized enone fatty acids resembling metabolites from gut microbiota suppress macrophage-mediated inflammation in adipocytes
- (2017) Ha-Eun Yang et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Histone deacetylase 3 prepares brown adipose tissue for acute thermogenic challenge
- (2017) Matthew J. Emmett et al. NATURE
- Histone deacetylases inhibitors (HDACis) as novel therapeutic application in various clinical diseases
- (2017) Xiaoyan Qiu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- HDAC3 is a molecular brake of the metabolic switch supporting white adipose tissue browning
- (2017) Alessandra Ferrari et al. Nature Communications
- HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity
- (2016) Niek G.J. Leus et al. BIOCHEMICAL PHARMACOLOGY
- Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation
- (2016) Niek GJ Leus et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Are epigenetic drugs for diabetes and obesity at our door step?
- (2016) Andrix O. Arguelles et al. DRUG DISCOVERY TODAY
- Inside HDACs with more selective HDAC inhibitors
- (2016) Joëlle Roche et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases
- (2016) Alokta Chakrabarti et al. Future Medicinal Chemistry
- Attenuation of diet-induced obesity and induction of white fat browning with a chemical inhibitor of histone deacetylases
- (2016) A Ferrari et al. INTERNATIONAL JOURNAL OF OBESITY
- Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation
- (2016) Fenfen Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone deacetylase inhibitors: Future therapeutics for insulin resistance and type 2 diabetes
- (2016) Sorabh Sharma et al. PHARMACOLOGICAL RESEARCH
- Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice
- (2016) Jian Hong et al. Oncotarget
- Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetes
- (2016) Chandrakumar Sathishkumar et al. Clinical Epigenetics
- Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning
- (2015) Tara M Henagan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- HDAC8: a multifaceted target for therapeutic interventions
- (2015) Alokta Chakrabarti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Unlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and Obesity
- (2015) Xiao-Rong Peng et al. Frontiers in Endocrinology
- Coupling of lipolysis and de novo lipogenesis in brown, beige, and white adipose tissues during chronic β3-adrenergic receptor activation
- (2014) Emilio P. Mottillo et al. JOURNAL OF LIPID RESEARCH
- Butyrate and other short-chain fatty acids increase the rate of lipolysis in 3T3-L1 adipocytes
- (2014) John M. Rumberger et al. PeerJ
- Improving Insulin Sensitivity With HDAC Inhibitor
- (2013) J. Ye DIABETES
- Modification of Enhancer Chromatin: What, How, and Why?
- (2013) Eliezer Calo et al. MOLECULAR CELL
- Brown and beige fat: development, function and therapeutic potential
- (2013) Matthew Harms et al. NATURE MEDICINE
- Synergism between cAMP and PPARγSignalling in the Initiation of UCP1 Gene Expression in HIB1B Brown Adipocytes
- (2013) H. Y. Chen et al. PPAR Research
- HDAC8 substrates: Histones and beyond
- (2012) Noah A. Wolfson et al. BIOPOLYMERS
- Inhibition of Class I Histone Deacetylases Unveils a Mitochondrial Signature and Enhances Oxidative Metabolism in Skeletal Muscle and Adipose Tissue
- (2012) A. Galmozzi et al. DIABETES
- Ephedrine activates brown adipose tissue in lean but not obese humans
- (2012) A. L. Carey et al. DIABETOLOGIA
- Metabolic reprogramming by class I and II histone deacetylases
- (2012) Maria M. Mihaylova et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
- (2012) Geneviève P Delcuve et al. Clinical Epigenetics
- Unknown
- (2011) Dan Christensen et al. MOLECULAR MEDICINE
- HDAC Inhibition Attenuates Inflammatory, Hypertrophic, and Hypertensive Responses in Spontaneously Hypertensive Rats
- (2010) Jeffrey P. Cardinale et al. HYPERTENSION
- Positive and negative control of Ucp1 gene transcription and the role of β-adrenergic signaling networks
- (2010) S Collins et al. INTERNATIONAL JOURNAL OF OBESITY
- Regulating the Regulators: The Post-Translational Code of Class I HDAC1 and HDAC2
- (2010) Chiara V. Segré et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
- (2010) Ya-Li Yao et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Histone H3K27ac separates active from poised enhancers and predicts developmental state
- (2010) M. P. Creyghton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylases: salesmen and customers in the post-translational modification market
- (2009) André Brandl et al. BIOLOGY OF THE CELL
- Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes
- (2009) Charlotte Ling et al. DIABETES
- Diosgenin attenuates inflammatory changes in the interaction between adipocytes and macrophages
- (2009) Shizuka Hirai et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Histone modifications at human enhancers reflect global cell-type-specific gene expression
- (2009) Nathaniel D. Heintzman et al. NATURE
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Dehydroabietic acid, a phytochemical, acts as ligand for PPARs in macrophages and adipocytes to regulate inflammation
- (2008) Min-Sook Kang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started